Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11951165 Conjugated vaccine carrier proteins

Patent 11951165 was granted and assigned to VaxCyte on April, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
VaxCyte
VaxCyte
0
Date Filed
July 1, 2019
0
Date of Patent
April 9, 2024
0
Patent Applicant
VaxCyte
VaxCyte
0
Patent Application Number
16459303
0
Patent Citations
‌
US Patent 7129333 Glycoprotein synthesis
0
‌
US Patent 7217791 Compositions and methods for treating or preventing pneumococcal infection
0
‌
US Patent 7312049 Total amino acid stabilization during cell-free protein synthesis
0
‌
US Patent 7338789 Methods of in vitro protein synthesis
0
‌
US Patent 7341852 Methods of decoupling reaction scale and protein synthesis yield in batch mode
0
‌
US Patent 7560535 Glycoprotein synthesis
0
‌
US Patent 7709001 Multivalent pneumococcal polysaccharide-protein conjugate composition
0
‌
US Patent 7718791 Separation of contaminants from
0
‌
US Patent 7825226 Glycoprotein synthesis
0
‌
US Patent 7867498 Polypeptide carrier protein
0
•••
Patent Inventor Names
Jeffery C. Fairman
0
Jon H. Heinrichs
0
Wei Chan
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11951165
0
Patent Primary Examiner
‌
Aradhana Sasan
0

Find more entities like US Patent 11951165 Conjugated vaccine carrier proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.